Podcast: Play in new window | Download
Subscribe: Apple Podcasts | RSS
About the Talent:
Michael J. Birrer, MD, PhD, Director of Medical Gynecologic Oncology, Massachusetts General Hospital
Dr. Michael Birrer is recognized nationally and internationally as an expert in gynecologic oncology. He has published over 270 peer reviewed manuscripts and another 27 book chapters and review articles. He has served in leadership positions within the greater gynecologic oncology community. He has been the Chair and Chair Emeritus of the DOD Ovarian Cancer Research Program, Chair of the Committee for Experimental Medicine of the Gynecologic Oncology Group, a member of the Gynecologic Cancer Steering Committee and Chair of the Translational Science Working Group of the Gynecologic Cancer Intergroup. Dr. Birrer has been a member of the Society of Gynecologic Oncology, American Society of Clinical Oncologists, American Association of Cancer Research and the International Gynecologic Cancer Society. He has been on the program committees of ASCO, SGO and IGCS.
In November 2008, Dr. Birrer was appointed Professor of Medicine at the Harvard School of Medicine. Dr. Birrer assumed the position of Director of Gynecologic Medical Oncology at MGH and the Gynecologic Oncology Research Program. This program integrates important new discoveries in translational research into clinical trials.
Richard T. Penson, MD, Clinical Director, Medical Gynecologic Oncology, Massachusetts General Hospital
Dr. Richard Penson is Associate Professor of Medicine at Harvard Medical School. Dr. Penson came from St Bartholomew’s Hospital, London, in 1997 and his practice is devoted almost exclusively to gynecologic oncology with the majority of patients having ovarian cancer. Dr. Penson sits on the national Gynecologic Oncology Group (GOG) committees for quality of life research, and the NCCN Ovarian Committee. Dr. Penson attends on the Bigelow General Medical Service at Mass General, serves as the chairman for panels C, and E of the Institutional Review Board of Dana- Farber/Partners CancerCare, and is a faculty member teaching on Patient Doctor I, for first year Harvard Medical students.
[Advocates/thought leaders will be included from the following markets]:
· Florida – Sue Friedman (FORCE)
· Kansas City – Sue Friedman (FORCE)
· Nashville – Sue Friedman (FORCE)
· Philadelphia – Diane Rose (FORCE), Wendy Homer (NOCC)
· Washington, DC – Phyllis Edelman (FORCE)
· Houston, Dallas, Fort Worth, TX – Sue Friedman (FORCE)
· Great Plains – Sue Friedman (FORCE)
This interview is provided by AstraZeneca